0

Paroxetine Related Compound D

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATCS31042716
Molecular Weight365.83
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Formneat
Gradepharmaceutical primary standard
Size10MG
1

A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor

Renee A Bouley, Zara Y Weinberg, Helen V Waldschmidt, Yu-Chen Yen, Scott D Larsen, Manojkumar A Puthenveedu, John J G Tesmer

Mol Pharmacol. 2020 Jun;97(6):392-401.

PMID: 32234810

1

Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis

Karen M Mustian, Catherine M Alfano, Charles Heckler, Amber S Kleckner, Ian R Kleckner, Corinne R Leach, David Mohr, Oxana G Palesh, Luke J Peppone, Barbara F Piper, John Scarpato, Tenbroeck Smith, Lisa K Sprod, etc.

JAMA Oncol. 2017 Jul 1;3(7):961-968.

PMID: 28253393

1

Neuropharmacology of Paroxetine

Charles B Nemeroff, Michael J Owens

Psychopharmacol Bull. Spring 2003;37 Suppl 1:8-18.

PMID: 14566196

1

Relationship Between Self-Administration of Amphetamine and Monoamine Receptors in Brain: Comparison With Cocaine

M C Ritz, M J Kuhar

J Pharmacol Exp Ther. 1989 Mar;248(3):1010-7.

PMID: 2703961

1

Target Identification and Mode of Action of Four Chemically Divergent Drugs Against Ebolavirus Infection

Jingshan Ren, Yuguang Zhao, Elizabeth E Fry, David I Stuart

J Med Chem. 2018 Feb 8;61(3):724-733.

PMID: 29272110

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode